The prescribed dosage for dexamethasone may depend on a person’s treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your dosage of ...
8d
MedPage Today on MSNWhat Did We Learn From the Earliest COVID Trials?The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...
2d
Asian News International on MSNRifampicin drug used in TB treatment is expected to be commissioned later this yearThe drug Rifampicin, which is used in serious bacterial infections, particularly Tuberculosis, is expected to be commissioned ...
Long COVID is arguably the most significant hangover from the pandemic. Here's what has been learned, and what remains ...
One sign of moon facies is that if you look at the patient directly, face to face, you can't see their ears. Other symptoms ...
During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences has its own resident expert in the fields of ...
Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.
The other important drugs like Prednisolone, Betamethasone and Dexamethasone are also expected to be commissioned this year.
Arcellx's innovative cell therapy platform shows promising potential in treating multiple myeloma, a significant unmet ...
"Many people said we shouldn't use dexamethasone because it suppresses the immune system when you're trying to fight an infection," he said. "Some wrote to the regulators saying we shouldn't allow ...
Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite challenges like cost and access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results